Morgan Stanley Adjusts MAOYAN ENT Target Price to HK$5.3, Maintains Market Perform Rating

Stock News07-28

Morgan Stanley has released a research report adjusting its outlook for MAOYAN ENT (01896).

The investment bank has reduced its non-IFRS net profit forecast for the company this year by 12%. This adjustment is primarily attributed to increased impairment losses on accounts receivable, as highlighted in the company's profit warning.

Furthermore, due to a slower-than-anticipated recovery in the film industry, Morgan Stanley believes MAOYAN ENT will continue to face accounts receivable risks next year. Consequently, the non-IFRS net profit forecast for the following year has been lowered by 6%.

Reflecting these changes in earnings projections, the target price for MAOYAN ENT has been reduced from HK$6.1 to HK$5.3. The firm has maintained its "Market Perform" rating on the stock.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1131358193?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-28 14:30","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1131358193","market":"nz","top_or_hot":-1,"title":"Morgan Stanley Adjusts MAOYAN ENT Target Price to HK$5.3, Maintains Market Perform Rating","media":"Stock News","content":"<p>Morgan Stanley has released a research report adjusting its outlook for <b>MAOYAN ENT</b> (<b>01896</b>).<br><br>The investment bank has reduced its non-IFRS net profit forecast for the company this year by 12%. This adjustment is primarily attributed to increased impairment losses on accounts receivable, as highlighted in the company's profit warning.<br><br>Furthermore, due to a slower-than-anticipated recovery in the film industry, Morgan Stanley believes <b>MAOYAN ENT</b> will continue to face accounts receivable risks next year. Consequently, the non-IFRS net profit forecast for the following year has been lowered by 6%.<br><br>Reflecting these changes in earnings projections, the target price for <b>MAOYAN ENT</b> has been reduced from HK$6.1 to HK$5.3. The firm has maintained its \"Market Perform\" rating on the stock.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Morgan Stanley Adjusts MAOYAN ENT Target Price to HK$5.3, Maintains Market Perform Rating</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMorgan Stanley Adjusts MAOYAN ENT Target Price to HK$5.3, Maintains Market Perform Rating\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-07-28 14:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Morgan Stanley has released a research report adjusting its outlook for <b>MAOYAN ENT</b> (<b>01896</b>).<br><br>The investment bank has reduced its non-IFRS net profit forecast for the company this year by 12%. This adjustment is primarily attributed to increased impairment losses on accounts receivable, as highlighted in the company's profit warning.<br><br>Furthermore, due to a slower-than-anticipated recovery in the film industry, Morgan Stanley believes <b>MAOYAN ENT</b> will continue to face accounts receivable risks next year. Consequently, the non-IFRS net profit forecast for the following year has been lowered by 6%.<br><br>Reflecting these changes in earnings projections, the target price for <b>MAOYAN ENT</b> has been reduced from HK$6.1 to HK$5.3. The firm has maintained its \"Market Perform\" rating on the stock.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1142","symbol_name":"互联网与直销零售","start_time":0,"source_url":"","article_id":"1131358193","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1131358193","pubTimestamp":1785220212,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Morgan Stanley has released a research report adjusting its outlook for MAOYAN ENT (01896).The investment bank has reduced its non-IFRS net profit forecast for the company this year by 12%. This...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1142":"互联网与直销零售","BK1591":"就地过年概念","EWH":"香港ETF-iShares MSCI","BK1128":"电影和娱乐","BK1581":"电影概念","01896":"猫眼娱乐","BK1516":"腾讯概念"},"translate_title":"摩根士丹利将猫眼耳鼻喉科目标价调整至5.3港元，维持市场表现评级","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EWH":1,"01896":1},"content_text":"Morgan Stanley has released a research report adjusting its outlook for MAOYAN ENT (01896).The investment bank has reduced its non-IFRS net profit forecast for the company this year by 12%. This adjustment is primarily attributed to increased impairment losses on accounts receivable, as highlighted in the company's profit warning.Furthermore, due to a slower-than-anticipated recovery in the film industry, Morgan Stanley believes MAOYAN ENT will continue to face accounts receivable risks next year. Consequently, the non-IFRS net profit forecast for the following year has been lowered by 6%.Reflecting these changes in earnings projections, the target price for MAOYAN ENT has been reduced from HK$6.1 to HK$5.3. The firm has maintained its \"Market Perform\" rating on the stock.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.47.1","shortVersion":"4.47.1","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1131358193","isCrawlerRequest":true}